Ramipril

This classification denotes an ace inhibitor with the molecular formula C23H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L35JN3I7SJ, chemically known as cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2s-(1(r*(r*)),2alpha,3abeta,6abeta))- but generally known as ramipril, which bears US NIH Compound Identifier 5362129. European Medicines Agency schedules Ramipril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10248MIG. The term RAMIPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules ramipril in its Anatomical Therapeutic Chemical (ATC) Classification. RAMIPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ramipril under HS 29339990 and SITC 51577. As of Q4 2014, RAMIPRIL remains the US FDA Preferred Term for this commodity. Ramipril bears US NLM identifiers UMLS ID C0072973 and NCI Concept Code C29411. SMILES: O=C(N1C2C(CC1C(=O)O)CCC2)C(NC(CCc1ccccc1)C(=O)OCC)C.